ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

UHT Universal Health Realty Income Trust

37.17
0.23 (0.62%)
21 Dec 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Universal Health Realty Income Trust NYSE:UHT NYSE Common Stock
  Price Change % Change Share Price High Price Low Price Open Price Shares Traded Last Trade
  0.23 0.62% 37.17 37.71 36.52 37.08 226,621 01:00:00

UNIVERSAL HEALTH REALTY INCOME TRUST REPORTS 2024 SECOND QUARTER FINANCIAL RESULTS

24/07/2024 9:15pm

PR Newswire (US)


Universal Health Realty ... (NYSE:UHT)
Historical Stock Chart


From Jun 2024 to Dec 2024

Click Here for more Universal Health Realty ... Charts.

Consolidated Results of Operations - Three-Month Periods Ended June 30, 2024 and 2023:

KING OF PRUSSIA, Pa., July 24, 2024 /PRNewswire/ -- Universal Health Realty Income Trust (NYSE:UHT) announced today that for the three-month period ended June 30, 2024, net income was $5.3 million, or $.38 per diluted share, as compared to $3.5 million, or $.25 per diluted share, during the second quarter of 2023.

The increase in our net income of $1.8 million, or $.13 per diluted share, during the second quarter of 2024, as compared to the comparable quarter of 2023, consisted of the following: (i) an increase of $1.5 million, or $.11 per diluted share, resulting from a reduction in the expenses related to our property located in Chicago, Illinois, including $862,000 from demolition expenses incurred during the second quarter of 2023, and $563,000 related to a property tax reduction recorded during the second quarter of 2024 which related primarily to prior periods; (ii) an increase of $706,000, or $.05 per diluted share, resulting from an aggregate net increase in the income generated at various properties, partially offset by; (iii) a decrease of $404,000, or $.03 per diluted share, resulting from an increase in interest expense due primarily to increases in our average borrowing rate as well as our average outstanding borrowings.

As calculated on the attached Schedule of Non-GAAP Supplemental Information ("Supplemental Schedule"), our funds from operations ("FFO") were $12.4 million, or $.90 per diluted share, during the second quarter of 2024, as compared to $10.6 million, or $.77 per diluted share during the second quarter of 2023. The increase of $1.8 million, or $.13 per diluted share, was due primarily to the above-mentioned increase in our net income during the second quarter of 2024, as compared to the second quarter of 2023.    

Consolidated Results of Operations - Six-Month Periods Ended June 30, 2024 and 2023:

For the six-month period ended June 30, 2024, net income was $10.6 million, or $.76 per diluted share, as compared to $7.9 million, or $0.57 per diluted share during the first six months of 2023.

The increase in our net income of $2.6 million, or $.19 per diluted share, during the first six months of 2024, as compared to the comparable period of 2023, consisted of the following: (i) an increase of $2.1 million, or $.15 per diluted share, resulting from an aggregate net increase in the income generated at various properties; (ii) an increase of $1.8 million, or $.13 per diluted share, resulting from a reduction in the expenses related to our property located in Chicago, Illinois, including $1.1 million from demolition expenses incurred during the first six months of 2023, and $563,000 related to a property tax reduction recorded during the first six months of 2024 which related primarily to prior periods, partially offset by; (iii) a decrease of $1.3 million, or $.09 per diluted share, resulting from an increase in interest expense due primarily to increases in our average borrowing rate as well as our average outstanding borrowings.

As calculated on the attached Supplemental Schedule, our FFO were $24.8 million, or $1.79 per diluted share, during the first six months of 2024, as compared to $22.0 million, or $1.59 per diluted share during the comparable period of 2023. The increase of $2.8 million, or $.20 per diluted share, was due primarily to the above-mentioned increase in our net income during the first six months of 2024, as compared to the first six months of 2023, as well as an increase in depreciation and amortization expense.    

Dividend Information:

The second quarter dividend of $.73 per share, or $10.1 million in the aggregate, was declared on June 5, 2024 and paid on June 28, 2024.

Capital Resources Information:

At June 30, 2024, we had $342.9 million of borrowings outstanding pursuant to the terms of our $375 million revolving credit agreement and $32.1 million of available borrowing capacity as of that date, net of outstanding borrowings.

Sierra Medical Plaza I:

In March, 2023, construction was substantially completed on the Sierra Medical Plaza I, an 86,000 square foot MOB located in Reno, Nevada. This MOB is located on the campus of the Northern Nevada Sierra Medical Center, a hospital that is owned and operated by a wholly-owned subsidiary of UHS, which was completed and opened during April, 2022. The master flex lease agreement in connection with this building, which commenced in March, 2023 and has a ten-year term scheduled to expire on March 31, 2033, covers approximately 68% of the rentable square feet of the MOB at an initial minimum rent of $1.3 million annually, plus a pro-rata share of the common area maintenance expenses. This master flex lease agreement is subject to reduction based upon the execution of third-party leases. The aggregate cost of the MOB is estimated to be approximately $35 million, approximately $30 million of which was incurred as of June 30, 2024.

Vacant Land/Specialty Facility:

Demolition of the former specialty hospital located in Chicago, Illinois, was completed during 2023. The aggregate demolition expenses amounted to approximately $1.5 million ($1.1 million of which were incurred during the first and second quarters of 2023 and $332,000 of which were incurred during the fourth quarter of 2022). In addition, in December, 2023, we sold the vacant specialty facility located in Corpus Christi, Texas. 

We continue to market the vacant properties located in Chicago, Illinois and Evansville, Indiana. Future operating expenses related to these properties, will be incurred by us during the time they remain owned and unleased.

General Information, Forward-Looking Statements and Risk Factors and Non-GAAP Financial Measures:

Universal Health Realty Income Trust, a real estate investment trust, invests in healthcare and human-service related facilities including acute care hospitals, behavioral health care hospitals, specialty facilities, medical/office buildings, free-standing emergency departments and childcare centers. We have investments or commitments in seventy-six properties located in twenty-one states.

This press release contains forward-looking statements based on current management expectations.  Numerous factors, including those disclosed herein, as well as the operations and financial results of each of our tenants, those related to healthcare industry trends and those detailed in our filings with the Securities and Exchange Commission (as set forth in Item 1A-Risk Factors and in Item 7- Forward-Looking Statements in our Form 10-K for the year ended December 31, 2023 and in Item 7 - Forward-Looking Statements and Certain Risk Factors in our Form 10-Q for the quarter ended March 31, 2024), may cause the results to differ materially from those anticipated in the forward-looking statements. Readers should not place undue reliance on such forward-looking statements which reflect management's view only as of the date hereof. We undertake no obligation to revise or update any forward-looking statements, or to make any other forward-looking statements, whether as a result of new information, future events or otherwise. 

Many of the factors that could affect our future results are beyond our control or ability to predict. Future operations and financial results of our tenants, and in turn ours, could be materially impacted by various developments including, but not limited to, decreases in staffing availability and related increases to wage expense experienced by our tenants resulting from the nationwide shortage of nurses and other clinical staff and support personnel, the impact of government and administrative regulation of the health care industry; declining patient volumes and unfavorable changes in payer mix caused by deteriorating macroeconomic conditions (including increases in uninsured and underinsured patients as the result of business closings and layoffs); potential disruptions related to supplies required for our tenants' employees and patients; and potential increases to other expenditures.

In addition, the increase in interest rates has substantially increased our borrowings costs and reduced our ability to access the capital markets on favorable terms.  Additional increases in interest rates could have a significant unfavorable impact on our future results of operations and the resulting effect on the capital markets could adversely affect our ability to carry out our strategy.       

 We believe that, if and when applicable, adjusted net income and adjusted net income per diluted share (as reflected on the Supplemental Schedule), which are non-GAAP financial measures ("GAAP" is Generally Accepted Accounting Principles in the United States of America), are helpful to our investors as measures of our operating performance. In addition, we believe that, when applicable, comparing and discussing our financial results based on these measures, as calculated, is helpful to our investors since it neutralizes the effect in each year of material items that are non-recurring or non-operational in nature including items such as, but not limited to, gains on transactions.

Funds from operations ("FFO") is a widely recognized measure of performance for Real Estate Investment Trusts ("REITs"). We believe that FFO and FFO per diluted share, which are non-GAAP financial measures, are helpful to our investors as measures of our operating performance. We compute FFO, as reflected on the attached Supplemental Schedules, in accordance with standards established by the National Association of Real Estate Investment Trusts ("NAREIT"), which may not be comparable to FFO reported by other REITs that do not compute FFO in accordance with the NAREIT definition, or that interpret the NAREIT definition differently than we interpret the definition. FFO adjusts for the effects of certain items, such as gains or losses on transactions that occurred during the periods presented.  FFO does not represent cash generated from operating activities in accordance with GAAP and should not be considered to be an alternative to net income determined in accordance with GAAP. In addition, FFO should not be used as: (i) an indication of our financial performance determined in accordance with GAAP; (ii) an alternative to cash flow from operating activities determined in accordance with GAAP; (iii) a measure of our liquidity, or; (iv) an indicator of funds available for our cash needs, including our ability to make cash distributions to shareholders. A reconciliation of our reported net income to FFO is reflected on the Supplemental Schedules included below.

To obtain a complete understanding of our financial performance these measures should be examined in connection with net income, determined in accordance with GAAP, as presented in the condensed consolidated financial statements and notes thereto in this report or in our other filings with the Securities and Exchange Commission including our Report on Form 10-K for the year ended December 31, 2023 and our Report on Form 10-Q for the quarter ended March 31, 2024. Since the items included or excluded from these measures are significant components in understanding and assessing financial performance under GAAP, these measures should not be considered to be alternatives to net income as a measure of our operating performance or profitability. Since these measures, as presented, are not determined in accordance with GAAP and are thus susceptible to varying calculations, they may not be comparable to other similarly titled measures of other companies. Investors are encouraged to use GAAP measures when evaluating our financial performance.

 

Universal Health Realty Income Trust

Consolidated Statements of Income

For the Three and Six Months Ended June 30, 2024 and 2023

(amounts in thousands, except share information)

(unaudited)




Three Months Ended



Six Months Ended



June 30,



June 30,



2024



2023



2024



2023

Revenues:












  Lease revenue - UHS facilities (a.)


$

8,454



$

8,236



$

17,118



$

16,023

  Lease revenue - Non-related parties



14,359




13,668




28,846




27,029

  Other revenue - UHS facilities



220




245




440




476

  Other revenue - Non-related parties



342




292




751




773

  Interest income on financing leases - UHS facilities



1,359




1,365




2,720




2,731




24,734




23,806




49,875




47,032

Expenses:












  Depreciation and amortization



6,806




6,849




13,615




13,467

  Advisory fees to UHS



1,369




1,323




2,707




2,625

  Other operating expenses



6,975




8,250




14,506




15,771




15,150




16,422




30,828




31,863

Income before equity in income of unconsolidated limited liability companies ("LLCs") and interest expense



9,584




7,384




19,047




15,169

  Equity in income of unconsolidated LLCs



272




268




656




639

  Interest expense, net



(4,580)




(4,176)




(9,127)




(7,873)

Net income


$

5,276



$

3,476



$

10,576



$

7,935

Basic earnings per share


$

0.38



$

0.25



$

0.77



$

0.58

Diluted earnings per share


$

0.38



$

0.25



$

0.76



$

0.57













Weighted average number of shares outstanding - Basic



13,798




13,784




13,795




13,781

Weighted average number of shares outstanding - Diluted



13,832




13,809




13,828




13,806


(a.) Includes bonus rental on McAllen Medical Center, a UHS acute care hospital facility, of $758 and $730 for the three-month periods ended June 30, 2024 and 2023, respectively, and $1,541 and $1,495 for the six-month periods ended June 30, 2024 and 2023, respectively.

 

Universal Health Realty Income Trust

Schedule of Non-GAAP Supplemental Information ("Supplemental Schedule")

For the Three Months Ended  June 30, 2024 and 2023

 (amounts in thousands, except share information)

(unaudited)


Calculation of Adjusted Net Income




Three Months Ended



Three Months Ended



June 30, 2024



June 30, 2023



Amount



Per
Diluted Share



Amount



Per
Diluted Share

Net income


$

5,276



$

0.38



$

3,476



$

0.25

Adjustments



-




-




-




-

Subtotal adjustments to net income



-




-




-




-

Adjusted net income


$

5,276



$

0.38



$

3,476



$

0.25


Calculation of Funds From Operations ("FFO")




Three Months Ended



Three Months Ended



June 30, 2024



June 30, 2023



Amount



Per
Diluted Share



Amount



Per
Diluted Share

Net income


$

5,276



$

0.38



$

3,476



$

0.25

Plus: Depreciation and amortization expense:












Consolidated investments



6,806




0.50




6,849




0.50

Unconsolidated affiliates



303




0.02




298




0.02

FFO


$

12,385



$

0.90



$

10,623



$

0.77

Dividend paid per share





$

0.730






$

0.720

 

Universal Health Realty Income Trust

Schedule of Non-GAAP Supplemental Information ("Supplemental Schedule")

For the Six Months Ended  June 30, 2024 and 2023

 (amounts in thousands, except share information)

(unaudited)


Calculation of Adjusted Net Income




Six Months Ended



Six Months Ended



June 30, 2024



June 30, 2023



Amount



Per
Diluted Share



Amount



Per
Diluted Share

Net income


$

10,576



$

0.76



$

7,935



$

0.57

Adjustments



-




-




-




-

Subtotal adjustments to net income



-




-




-




-

Adjusted net income


$

10,576



$

0.76



$

7,935



$

0.57


Calculation of Funds From Operations ("FFO")















Six Months Ended



Six Months Ended



June 30, 2024



June 30, 2023



Amount



Per
Diluted Share



Amount



Per
Diluted Share

Net income


$

10,576



$

0.76



$

7,935



$

0.57

Plus: Depreciation and amortization expense:












Consolidated investments



13,615




0.99




13,467




0.98

Unconsolidated affiliates



607




0.04




591




0.04

FFO


$

24,798



$

1.79



$

21,993



$

1.59

Dividend paid per share





$

1.455






$

1.435

 

Universal Health Realty Income Trust

Consolidated Balance Sheets

(amounts in thousands, except share information)

(unaudited)




June 30,



December 31,



2024



2023

Assets:






Real Estate Investments:






Buildings and improvements and construction in progress


$

651,638



$

649,374

Accumulated depreciation



(274,622)




(262,449)




377,016




386,925

Land



56,870




56,870

               Net Real Estate Investments



433,886




443,795

Financing receivable from UHS



83,043




83,279

               Net Real Estate Investments and Financing receivable



516,929




527,074

Investments in limited liability companies ("LLCs")



14,328




9,102

Other Assets:






Cash and cash equivalents



5,577




8,212

Lease and other receivables from UHS



6,816




6,180

Lease receivable - other



7,905




8,166

Intangible assets (net of accumulated amortization of $11.4 million and
   $12.5 million, respectively)



8,193




9,110

Right-of-use land assets, net



10,932




10,946

Deferred charges, notes receivable and other assets, net



15,871




17,579

               Total Assets


$

586,551



$

596,369

Liabilities:






Line of credit borrowings


$

342,900



$

326,600

Mortgage notes payable, non-recourse to us, net



19,970




32,863

Accrued interest



1,024




490

Accrued expenses and other liabilities



10,145




13,500

Ground lease liabilities, net



10,932




10,946

Tenant reserves, deposits and deferred and prepaid rents



10,879




11,036

               Total Liabilities



395,850




395,435

Equity:






Preferred shares of beneficial interest,
   $.01 par value; 5,000,000 shares authorized;
   none issued and outstanding



-




-

Common shares, $.01 par value;
   95,000,000 shares authorized; issued and outstanding: 2024 - 13,848,950;
   2023 - 13,823,899



138




138

Capital in excess of par value



270,592




270,398

Cumulative net income



836,637




826,061

Cumulative dividends



(923,107)




(902,975)

Accumulated other comprehensive income



6,441




7,312

     Total Equity



190,701




200,934

               Total Liabilities and Equity


$

586,551



$

596,369

 

Cision View original content:https://www.prnewswire.com/news-releases/universal-health-realty-income-trust-reports-2024-second-quarter-financial-results-302205694.html

SOURCE Universal Health Realty Income Trust

Copyright 2024 PR Newswire

1 Year Universal Health Realty ... Chart

1 Year Universal Health Realty ... Chart

1 Month Universal Health Realty ... Chart

1 Month Universal Health Realty ... Chart

Your Recent History